Aurinia Pharmaceuticals Inc. (AUPH) vs AxoGen, Inc. (AXGN)

A side-by-side comparison of Aurinia Pharmaceuticals Inc. and AxoGen, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — AUPH vs AXGN

growth of $100 · dividends reinvested · last 10y
AUPH +288.1% (+14.5%/yr)AXGN +332.8% (+15.8%/yr)AXGN compounded faster over this window
0200400600800Start $10020182020202220242026$388$433
AUPH AXGN

AUPH vs AXGN: by the numbers

  • •AUPH is the larger company ($2.03B vs $2.00B market cap).
  • •AUPH is profitable (100.84% net margin) while AXGN runs a net loss (-13.36%).
  • •AUPH grew revenue faster over the past five years (40.17% vs 13.99% CAGR).

Metrics side by side

Valuation

MetricAUPHAXGN
P/E ratio6.89N/A
Forward P/E16.7184.14
P/S ratio6.517.97
P/B ratio3.307.81
EV / EBITDA11.22N/A
FCF yield8.56%0.13%

Profitability

MetricAUPHAXGN
Gross margin90.36%74.56%
Operating margin37.06%-5.12%
Net margin100.84%-13.36%
ROE51.09%-13.09%
ROIC21.77%-4.68%

Growth (annualized)

MetricAUPHAXGN
Revenue CAGR (5Y)40.17%13.99%
Total return CAGR (5Y)-5.88%19.40%

Frequently asked

Which has grown faster, AUPH or AXGN?
Over the past five years, AUPH grew revenue faster — AUPH at a 40.17% CAGR versus AXGN at 13.99%.
Is AUPH or AXGN more profitable?
AUPH runs the higher net margin — AUPH at 100.84% versus AXGN at -13.36%.
How have AUPH and AXGN total returns compared?
Over the past 10 years, AUPH delivered 14.53% and AXGN delivered 15.98% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.